Helping clients meet their business challenges begins with an in-depth understanding of the industries in which they work. That’s why KPMG LLP established its industry-driven structure. In fact, KPMG LLP was the first of the Big Four firms to organize itself along the same industry lines as clients.

How We Work

We bring together passionate problem-solvers, innovative technologies, and full-service capabilities to create opportunity with every insight.

Learn more

Careers & Culture

What is culture? Culture is how we do things around here. It is the combination of a predominant mindset, actions (both big and small) that we all commit to every day, and the underlying processes, programs and systems supporting how work gets done.

Learn more

Dr. Varun Renjen

Managing Director, Life Sciences Deal Advisory and Strategy, KPMG US

Short Hills, NJ
Image of Dr. Varun Renjen

Dr. Varun Renjen

Managing Director, Life Sciences Deal Advisory and Strategy

Varun is a physician with over 11 years of experience in strategy consulting in the life sciences industry with additional academic medical research experience. His areas of focus are commercial strategy, growth strategy, medical affairs and M&A for life science companies worldwide. He has supported both big pharma companies as well as emerging earlier stage companies on a variety of strategic issues. As a trained physician, Varun has worked and supported across all therapeutic areas focus and has been a clinical SME across projects.

A particular focus is in the growing field of CNS in both neurology and psychiatry Varun has supported biopharma clients in CNS across a variety of strategic issues including disease area strategy, portfolio strategy and optimization, corporate strategy, pricing and market access, medical affairs strategy, and M&A strategy for inorganic growth. He has published thought leadership on a variety of CNS topics and has attended several CNS specific conferences over the course of his career.

Professional and Industry Experience:

  • CNS disease area strategy for leading CNS company for a 5-10 year horizon 
  • Corporate strategy for leading CNS company focused on inorganic growth strategy 
  • Portfolio optimization for leading CNS company to help maximize R&D investment across prioritized developmental programs 
  • Cell and gene therapy disease area strategy over 10 year period with focus on solid tumor development 
  • Immunology disease area strategy with focus on organic and inorganic growth over 10 year period 
  • Biomarker strategy for leading company interested in developing novel assets for 1L DLBCL 
  • Commercial due diligence for novel Parkinson’s disease modifying therapy

Thank you!

Thank you for contacting KPMG. We will respond to you as soon as possible.

Contact KPMG

Use this form to submit general inquiries to KPMG. We will respond to you as soon as possible.

By submitting, you agree that KPMG LLP may process any personal information you provide pursuant to KPMG LLP's Privacy Statement.

An error occurred. Please contact customer support.

Job seekers

Visit our careers section or search our jobs database.

Submit RFP

Use the RFP submission form to detail the services KPMG can help assist you with.

Office locations

International hotline

You can confidentially report concerns to the KPMG International hotline

Press contacts

Do you need to speak with our Press Office? Here's how to get in touch.